Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Strategies for Data-Driven Investigations of Disease and Decreased Production on Stocker Operations.

The Veterinary clinics of North America. Food animal practice·2026
Same author

Stocker Production Medicine: An Emerging Area of Specialization in Modern Food Animal Practice.

The Veterinary clinics of North America. Food animal practice·2026
Same author

Detection and Genomic Characterization of Novel Respiratory Viruses in US and Mexican Cattle Farms.

Transboundary and emerging diseases·2026
Same author

A Systems Perspective on Developing and Improving Data Infrastructure on Stocker Cattle Operations.

The Veterinary clinics of North America. Food animal practice·2026
Same author

Engineering auxin degradation into root-associated bacteria promotes plant growth.

bioRxiv : the preprint server for biology·2025
Same author

Oleoyl coenzyme A triggers peroxygenase activity in cytochrome c.

Journal of inorganic biochemistry·2025
Same journal

Carbonylative Aminative Suzuki-Miyaura Coupling: Pd-Catalyzed Synthesis of Amides from Vinyl/Aryl Halides and Boronic Acids.

Journal of the American Chemical Society·2026
Same journal

Divergent Asymmetric Synthesis of Glutinosasins A-E.

Journal of the American Chemical Society·2026
Same journal

Ultrastrong Polyketone Hot-Melt Adhesives Enabled by Ni-Catalyzed Carbonylative Polymerization.

Journal of the American Chemical Society·2026
Same journal

Programmable Anomalous Photovoltaics Enabled by Light-Electric Dual-Field Control.

Journal of the American Chemical Society·2026
Same journal

Biomimetic Redox-Mediated Proton Relay in Nanoreactors for Photocatalysis.

Journal of the American Chemical Society·2026
Same journal

The Sulfur Monoxide-Water Complex.

Journal of the American Chemical Society·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 22, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

非常に反応性の高いp450モデル化合物です.

Seth R Bell1, John T Groves

  • 1Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA.

Journal of the American Chemical Society
|June 26, 2009
PubMed
まとめ
この要約は機械生成です。

この研究では,シトクロームP450モデル化合物I, [OFe(IV) -4-TMPyP] ((+) (1) の急速なC-H水酸化反応の詳細が示されています. 研究は,その異常な反応速度を強調し,これらの重要な生物学的触媒における高い反応性のメカニズムについての洞察を提供します.

さらに関連する動画

Preparation of SNS Cobalt(II) Pincer Model Complexes of Liver Alcohol Dehydrogenase
06:31

Preparation of SNS Cobalt(II) Pincer Model Complexes of Liver Alcohol Dehydrogenase

Published on: March 19, 2020

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

関連する実験動画

Last Updated: Jun 22, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Preparation of SNS Cobalt(II) Pincer Model Complexes of Liver Alcohol Dehydrogenase
06:31

Preparation of SNS Cobalt(II) Pincer Model Complexes of Liver Alcohol Dehydrogenase

Published on: March 19, 2020

High-Throughput Metabolic Profiling for Model Refinements of Microalgae
11:07

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

科学分野:

  • バイオケミストリーとバイオ物理化学
  • 有機金属化学 有機金属化学
  • カタリシス カタリシス カタリシス

背景:

  • サイトクロームP450酵素は,幅広い基質の代謝に不可欠です.
  • その活性部位,特に化合物Iの反応性を理解することは,その生物学的機能を解明する鍵となる.
  • モデル化合物は,これらの複雑なシステムの基本的な化学を研究するために不可欠です.

研究 の 目的:

  • 特定のサイトクロームP450化合物Iモデルを検出し,運動的に特徴づけるために, [OFe(IV) -4-TMPyP](+) (1).
  • このモデル化合物によって媒介されるC-H水酸化の反応速度とメカニズムを調査する.
  • 観測された反応性を,モデルの電子的および構造的性質と相関させる.

主な方法:

  • 中間物質の形成と分解をモニタリングするための停止フロースペクトロフォトメトリー.
  • 核磁共振 (NMR) スペクトロスコーピー (1Hと13C) で,反応産物を特定する.
  • 電子スプレー・イオン化質量スペクトロメトリー (ESI-MS) で,酸素の吸収を測定する.
  • デュテラート基板を用いた運動同位体効果の研究.

主要な成果:

  • 中間物質 [OFe(IV) -4-TMPyP](+) (1) は,形成の高次元の速度定数 (1.59 x 107 M−1s−1) と検出されました.
  • 化合物1は,C−H水酸化の異常な二次速度定数を示した (例えば,キサンテンの場合は3.6 x 106 M−1s−1).
  • 製品分析と動的同位体効果は,同解性水素抽出機構を示唆している.
  • 酸素リバウンドとブロンステッド・エヴァンス・ポランイア分析は,移行状態と結合エネルギーに関する洞察を提供した.

結論:

  • サイトクロームP450モデル化合物I, [OFe (((IV) -4-TMPyP] (((+)) は,C-H水酸化で非常に高い反応性を示しています.
  • この反応性の起源として,高ポルフィリン・レドックス・ポテンシャルとスピン状態の交差現象が提案されている.
  • 微妙な活性部位の修正は,P450酵素の触媒効率を大幅に高めることができます.